「Debut Biotechnology」宣布公司在B轮融资中获得3400万美元融资，以用于业务范围的扩大。该轮融资由BOLD领投，Fine Structure Ventures、Material Impact、GS Futures、Cavallo Ventures、Cultivian Sandbox Ventures、ACVC Partners等参与。 据悉，Debut Biotechnolog ...

Vir Biotechnology develops antibody and RNA-based therapies for infectious diseases, leveraging partnerships and a robust ...

今天，Unity Biotechnology 宣布获得 1.16 亿美元 B 轮融资，由亚马逊 CEO Jeff Bezos 领投，梅奥医学中心、苏格兰互惠基金 Baillie Gifford、Venrock、生命科学投资机构 ARCH Venture Capital 和药明康德等参投。公司计划利用本轮融资扩大目前正在进行中的细胞衰老研究计划，并推进公司首个临床前项目进入人体试验阶段。

Vir Biotechnology develops immunology-based therapies for infectious diseases, backed by collaborations and a diversified ...

Vir Biotechnology has a cash runway into 2028 and pivotal 2026 catalysts for its lead hepatitis drugs. Learn why VIR stock is ...

Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...

Built for scientists, CodeLifeAI unifies biological design, molecular modelling, AI-assistant, and research management ...

Biotechnology has enormous potential to solve some of the world’s most pressing challenges in health, food security, and the environment. Yet conventional methods ...

The biotechnology instruments market is growing due to personalized medicine, genomics, and molecular diagnostics.

"We anticipate dosing the first patient in the combination dose expansion cohorts in both early-line MCRPC and metastatic hormone-sensitive prostate cancer over the coming months." (President, CEO & ...

Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...